干扰Sema4D基因表达对胰腺癌细胞生物学特征的影响

侯丽艳; 贾如江; 任利兵; 杨庚武

doi:10.3969/j.issn.1001-5256.2018.02.026

干扰Sema4D基因表达对胰腺癌细胞生物学特征的影响

DOI: 10.3969/j.issn.1001-5256.2018.02.026

1. 邯郸市中心医院重症医学科
2. 邯郸市中心医院普外一科

基金项目:

河北省卫计委计划项目(20150457)；

详细信息

中图分类号: R735.9
计量
- 文章访问数: 2307
- HTML全文浏览量: 51
- PDF下载量: 401
- 被引次数: 0
出版历程
- 出版日期: 2018-02-20

Effect of interference of Sema4D expression on cell biological characteristics in pancreatic cancer

Department of Critical Care Medicine, Handan Central Hospital

Research funding:

摘要

摘要:
目的探讨干扰Sema4D基因的表达对胰腺癌细胞生物学的影响。方法设计合成Sema4D-siRNA,转染到人胰腺癌细胞系中,将实验分为3组,转染siRNA组、阴性对照组（即转染非特异性对照组）﹑空白对照组（未经任何处理的胰腺癌细胞）。转染48 h后利用RT-q PCR检测转染前后Sema4D mRNA表达的变化,转染72 h后利用Western-Blot的方法检测转染前后Sema4D蛋白表达的变化;采用四甲基偶氮唑蓝显色法观察转染后细胞生长变化;Transwell小室侵袭试验检测转染后肿瘤细胞侵袭性的改变;采用流式细胞技术检测肿瘤细胞凋亡的变化。计量资料多组间比较采用单因素方差分析比较,进一步两两比较采用LSD-t检验法。结果转染Sema4D-siRNA 48 h后,转染siRNA组Sema4D mRNA的表达明显低于阴性对照组和空白对照组,3组比较差异有统计学意义（F=421.990,P<0.001）。转染Sema4D-siRNA 72 h后,转染siRNA组Sema4D蛋白明显低于阴性对照组和空白对照组,3组间比较差异有统计学意义（F=27.074,P=0.002 3）。转染s...
- 胰腺肿瘤 /
- 细胞增殖 /
- 细胞凋亡 /
- 肿瘤侵润 /
- RNA干扰
Abstract:
Objective To investigate the effect of interference of Sema4D expression on cell biological behavior in pancreatic cancer.Methods Sema4D-siRNA was designed, synthesized, and transfected into a human pancreatic cancer cell line.The cells were divided into siRNA transfection group, negative control group (nonspecific transfection group) , and blank control group (untreated pancreatic cancer cells) .RT-q PCR was used to measure the change in the mRNA expression of Sema4D at 48 hours after transfection, and Western blot was used to measure the change in the protein expression of Sema4D at 72 hours after transfection.MTT assay was used to observe the change in cell growth after transfection, Transwell chamber invasion assay was used to observe the change in tumor cell invasion after transfection, and flow cytometry was used to observe the change in the apoptosis of tumor cells.An analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between any two groups.Results At 48 hours after Sema4D-siRNA transfection, the siRNA transfection group had significantly lower mRNA expression of Sema4D than the negative control group and the blank control group (F = 421.990, P < 0.001) .At 72 hours after Sema4D-siRNA transfection, the siRNA transfection group had significantly lower protein expression of Sema4D than the negative control group and the blank control group (F = 27.074, P =0.002 3) .At 48, 72, and 96 hours after transfection, the siRNA transfection group had a significantly lower cell growth rate than the negative control group and the blank control group (F = 15.314, 62.255, and 223.493, P = 0.004, < 0.001, and < 0.001) .The siRNA transfection group had a significantly lower number of cells which crossed the membrane than the negative control group and the blank control group (42.0 ± 5.9 vs 60.0 ± 6.1 vs 61.0 ± 4.6, F = 37.21, P = 0.000 4) .The siRNA transfection group had a significantly lower apoptosis rate than the negative control group and the blank control group [ (16.57 ± 0.31) % vs (9.50 ± 0.45) % vs (9.90 ± 0.61) %, F =26.75, P = 0.007 4].Conclusion Sema4D-siRNA can downregulate the expression of Sema4D in pancreatic cells and can inhibit the proliferation of pancreatic cancer cells and reduce their invasion ability and apoptosis.
- pancreatic neoplasms /
- cell proliferation /
- apoptosis /
- neoplasm invasiveness /
- RNA interference

HTML全文

参考文献(13)

[1]CHEN L, YU RS.Imaging diagnosis of pancreatic cancer and preoperative imaging evaluation of resectability and staging[J].J Clin Hepatol, 2016, 32 (12) :2305-2311. (in Chinese) 陈璐, 余日胜.胰腺癌的影像学诊断及术前可切除性和分期的影像学评估[J].临床肝胆病杂志, 2016, 32 (12) :2305-2311.

[2] KATO S, KUBOTA K, SHIMAMURA T, et al.Semaphorin 4D:a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexin B1, in pancreatic cancer[J].Cancer Sci, 2011, 102 (11) :2029-2037.

[3]CHEN WG, SHEN WW, HU X, et al.Effects of siRNA-mediated Semaphorin 4D silencing on proliferation and migration of human breast cancer MDA-MB-231 cells[J].Chin J Cancer Biother, 2015, 22 (4) :454-458. (in Chinese) 陈武桂, 沈伟伟, 胡旭, 等.siRNA沉默Sema4D对乳腺癌MDA-MB-231细胞增殖及迁移的影响[J].中国肿瘤生物治疗杂志, 2015, 22 (4) :454-458.

[4]XU XD, YANG L, ZHENG LY, et al.Suberoylanilidehydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells[J].BMC Cancer, 2014, 14:373.

[5] ZHAO YP.Surgeons should pay abundant attention to the clinical research for pancreatic cancer[J].Chin J Dig Surg, 2016, 15 (6) :534-536. (in Chinese) 赵玉沛.外斜医师要重视胰腺癌的临床研究[J].中华消化外科杂志, 2016, 15 (6) :534-536.

[6]YOUNIS RH, HAN KL, WEBB TJ.Human head and neck squamous cell carcinoma-associated Semaphorin 4D induces expansion of myeloid-derived suppressor cells[J].J Immunol, 2016, 196 (3) :1419-1429.

[7] SUN Q, ZHOU H, BINMADI NO, et al.Hypoxia-inducible factor-1-mediated regulation of Semaphorin 4D affects tumor growth and vascularity[J].J Biol Chem, 2009, 284 (46) :32066-32074.

[8]KATO S, KUBOTA K, SHIMAMURAT, et al.Semaphorin 4D:a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexin B1, in pancreatic cancer[J].Cancer Sci, 2011, 102 (11) :2029-2037.

[9]PATNAIK A, WEISS GJ, LEONARD JE, et al.Safety, pharmacokinetics, and pharmacodynamics of a humanized anti-Semaphorin4D antibody, in a first-in-human study of patients with advanced solid tumors[J].Clin Cancer Res, 2016, 22 (4) :827-836.

[10]SUN Q, ZHOU H, BINMADI NO, et al.Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity[J].J Biol Chem, 2009, 284 (46) :32066-32074.

[11]ZHOU H, YANG YH, BASILE JR.The Semaphorin 4D-Plexin-B1-Rho A signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4[J].Angiogenesis, 2014, 17 (1) :261-274.

[12]ZHANG T, CHEN GD, HE GS, et al.Expression and significance of Axin2 in pancreatic cancer cells[J].J Clin Hepatol, 2016, 32 (5) :876-879. (in Chinese) 张涛, 陈国栋, 贺更生, 等.Axin 2在胰腺癌细胞中的表达及意义[J].临床肝胆病杂志, 2016, 32 (5) :876-879.

[13]LIU JW, LU Y, YAO WF, et al.Proliferation inhibition and apoptosis induction effect of FTY720 on pancreatic carcinoma MIAPa Ca-2 cells[J].Chin J Clin Pharmacol Ther, 2016, 21 (6) :621-624. (in Chinese) 刘军伟, 卢毅, 姚伟峰, 等.芬戈莫德对胰腺癌MIAPa Ca-2细胞增殖和凋亡的作用[J].中国临床药理学与治疗学, 2016, 21 (6) :621-624.

施引文献

资源附件(0)

访问统计